Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 18555 [2011-7882]

Download as PDF 18555 Federal Register / Vol. 76, No. 64 / Monday, April 4, 2011 / Notices ESTIMATE OF ANNUALIZED BURDEN TABLE—Continued Number of responses per respondent Number of respondents Average burden per response (in hours) Total burden (in hours) Target population Data collection form Eligible HIV-positive individuals .......................... Clinic Survey .................. 800 1 25/60 333 Total ............................................................. ......................................... ........................ ........................ ........................ 829 [FR Doc. 2011–7882 Filed 4–1–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Dated: March 29, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P [FR Doc. 2011–7886 Filed 4–1–11; 8:45 am] Dated: March 29, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–7883 Filed 4–1–11; 8:45 am] Daniel Holcomb, Reports Clearance Officer, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Statement of Organization, Functions, and Delegations of Authority DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Emcdonald on DSK2BSOYB1PROD with NOTICES The meeting announced below concerns Virologic Evaluation of the Modes of Influenza Virus Transmission among Humans, Funding Opportunity Announcement (FOA), IP11–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., May 17, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Virologic Evaluation of the Modes of Influenza Virus Transmission among Humans, FOA IP11–001.’’ Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. VerDate Mar<15>2010 18:47 Apr 01, 2011 Jkt 223001 The meeting announced below concerns Economic Studies of Vaccines and Immunization Policies, Programs, and Practices, Funding Opportunity Announcement (FOA), IP11–007, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12 p.m.–2 p.m., June 14, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Economic Studies of Vaccines and Immunization Policies, Programs, and Practices, FOA IP11–007, initial review.’’ Contact Person for More Information: Amy Yang, PhD, Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2733. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Part F of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS), (Federal Register, Vol. 75, No. 56, pp. 14178, dated Wednesday, March 24, 2010) is amended to reflect updates to the functions for the Center for Strategic Planning (FCK). Part F. is described below: • Section FC. 20. (Functions) reads as follows: Center for Strategic Planning (FCK) • Provide senior leadership over the strategic planning process and the development of CMS strategic goals, metrics, and plans. • Direct the development of financial and health care trend analysis and management insight report to inform senior CMS leadership strategic decision making. • Set priorities for CSP direction, budget, personnel, and staff development. • Translate statistical data into information useful to agency leadership. • Provide leadership to the development of performance dashboards and databases for key agency initiatives. • Provide leadership in maintaining and ensuring quality of data resources needed for testing and evaluating demonstrations and innovations. • Direct the development of enterprise business plans, process requirement for CMS post ACA E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 76, Number 64 (Monday, April 4, 2011)]
[Notices]
[Page 18555]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7882]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Economic Studies of Vaccines 
and Immunization Policies, Programs, and Practices, Funding Opportunity 
Announcement (FOA), IP11-007, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12 p.m.-2 p.m., June 14, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Economic Studies of Vaccines and Immunization 
Policies, Programs, and Practices, FOA IP11-007, initial review.''
    Contact Person for More Information: Amy Yang, PhD, Scientific 
Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, 
Georgia 30333, Telephone: (404) 498-2733.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-7882 Filed 4-1-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.